On 6 February 2026, ETHK Labs Inc. (華檢醫療控股有限公司, Stock Code: 1931) released an announcement presenting its Board of Directors. The Board comprises Executive Directors Lin Xianya (General Manager), Chan Siu Kei Ken, and Yi Xiao (Chief Scientist), Non-executive Directors Yao Haiyun and Liu Fei, as well as Independent Non-executive Directors Zhong Renqian, Xu Da, and Zhang Jianlei.

The announcement also outlines the committees on which Board members serve. Zhang Jianlei chairs the Audit, Remuneration, and Nomination Committees. Xu Da and Zhong Renqian are members of both the Audit and Remuneration Committees, with Xu Da additionally serving on the Nomination Committee. Chan Siu Kei Ken is also a member of the Nomination Committee.